INLYTA is a prescription medicine used to treat advanced kidney cancer (advanced renal cell carcinoma or RCC) when one prior drug treatment for this disease has not worked or has stopped working.
 
Learn more about INLYTA and how it helps fight tumors
INLYTA (pronounced “in-LIGHT-ah”) was approved by the US Food and Drug Administration (FDA) on January 27, 2012. INLYTA is a prescription medicine used to treat advanced kidney cancer (advanced renal cell carcinoma or RCC) when one prior drug treatment for this disease has not worked or has stopped working.
How INLYTA helps fight tumors
Learn how INLYTA is thought to
work to help fight the growth and spread of tumors.
Taking INLYTA
Find out what to tell your doctor before you start taking INLYTA and how to take it.
INLYTA study results
Review results from a head-to-head clinical trial comparing INLYTA with Nexavar® (sorafenib).